Advertisement

Topics

Flatiron Taps Vasoncelles of Unum Therapeutics for Chief Medical Officer

16:37 EDT 14 Jun 2019 | Xconomy

Michael Vasoncelles has joined Flatiron Health as chief medical officer, the same position he held at Unum Therapeutics. Vasoncelles’ experience also includes posts at Takeda Pharmaceutical (NYSE: TAK), Genzyme, and Sanofi (NYSE: SNY). At New York-based Flatiron, Vasoncelles will succeed Amy Abernethy, who left earlier this year to join the FDA as principal deputy commissioner. […]

Original Article: Flatiron Taps Vasoncelles of Unum Therapeutics for Chief Medical Officer

NEXT ARTICLE

More From BioPortfolio on "Flatiron Taps Vasoncelles of Unum Therapeutics for Chief Medical Officer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...